Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine in Rabigh, King Abdulaziz University, P.O Box 80205, Jeddah, 21589, Saudi Arabia.
Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
J Otolaryngol Head Neck Surg. 2020 Sep 29;49(1):69. doi: 10.1186/s40463-020-00463-0.
Chronic rhinosinusitis (CRS) negatively affects quality of life (QoL), and balloon catheter sinuplasty (BCS) has shown good outcomes in adult patients. However, there has not been much research on the effects of BCS on pediatric patients. The objective of this review is to systematically assess the literature for studies demonstrating the effectiveness and safety of BCS in pediatric CRS patients.
PubMed, Embase and Cochrane Library.
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis recommendations (PRISMA) to conduct our study. Observational- and interventional-based studies reporting efficacy and/or side effects of BCS among pediatric populations were included. Efficacy was evaluated by clinically reliable measures including Sino-Nasal 5 (SN-5) QoL scale. Antibiotic usage and revision surgery were also evaluated.
Articles were screened, and data were obtained. Study design, sample size and demographics, treated sinuses, criteria of inclusion, adjunct procedure(s), follow-up time, and outcomes measured were reported.
Out of 112 articles identified, 10 articles were included: two interventional controlled trials and eight observational studies. All studies evaluating QoL by SN-5 showed a remarkable reduction in SN-5 score postoperatively. Improvement in the computed tomography (CT) and endoscopic findings for up to 1 year after operation was reported. Furthermore, the majority of patinets treated with BCS did not recieve any course of sinusitis-indicated antibiotics during long-term follow-up, and they had low surgical revision rates. Minor side effects were reported, most commonly synechia.
Available evidence suggests that BCS is safe and effective for the treatment of CRS in pediatric patients. Future randomized controlled studies with large sample size are warranted. Such studies can further determine the efficacy of BCS in managing children with CRS.
慢性鼻-鼻窦炎(CRS)会降低生活质量(QoL),球囊导管鼻窦成形术(BCS)已显示出在成年患者中的良好效果。然而,针对儿科患者,BCS 的效果研究较少。本综述的目的是系统评估文献,以确定 BCS 治疗小儿 CRS 患者的有效性和安全性。
PubMed、Embase 和 Cochrane Library。
我们遵循系统评价和荟萃分析的首选报告项目(PRISMA)建议进行研究。纳入了报告儿科人群中 BCS 疗效和/或副作用的观察性和干预性研究。通过包括 Sino-Nasal 5(SN-5)生活质量量表在内的临床可靠指标评估疗效。还评估了抗生素使用和修正手术。
筛选文章并获取数据。报告研究设计、样本量和人口统计学、治疗鼻窦、纳入标准、辅助治疗(若有)、随访时间和测量的结果。
在 112 篇文章中,有 10 篇被纳入:两项干预性对照试验和八项观察性研究。所有评估 SN-5 生活质量的研究均显示术后 SN-5 评分显著降低。术后 1 年内 CT 和内镜检查结果得到改善。此外,大多数接受 BCS 治疗的患者在长期随访中无需接受任何鼻窦炎症抗生素治疗,且手术修正率较低。报告了一些轻微的副作用,最常见的是粘连。
现有证据表明,BCS 治疗小儿 CRS 安全且有效。需要进行未来的随机对照研究,以确定其在治疗儿童 CRS 中的疗效。